Answers · IP Strategy & Portfolio
What IP and innovation-pipeline KPIs should a CTO track?
Updated August 2026
The short answer
Six KPIs cover most of what a CTO needs: invention disclosures per technologist per year, disclosure-to-filing conversion rate, share of filings mapped to shipping products, citation and coverage measures against named competitors, maintenance spend by value tier, and cycle time from disclosure to filing decision. Review them quarterly; the trend line matters more than any quarter's level.
Two external benchmarks for calibration: industry surveys suggest only about a third of technologists ever submit an invention disclosure, and commonly cited triage benchmarks convert 20 to 40 percent of disclosures into filings.
The six KPIs and what each one tells you
| KPI | What it tells you |
|---|---|
| Invention disclosures per technologist per year | Whether invention is being captured or silently lost. Trend matters more than level; falling rates signal a process problem. |
| Disclosure-to-filing conversion rate | Whether triage has teeth. Commonly cited benchmarks run 20 to 40 percent; near 100 percent means no selection is happening. |
| Share of filings mapped to shipping products | Whether the patent budget protects revenue. The single best alignment number to show a board. |
| Citation and coverage vs. named competitors | Where you sit in the landscape: who builds on your work, who crowds your roadmap, and where white space remains. |
| Maintenance spend by value tier | Whether escalating renewal fees concentrate on high-value patents or leak into assets no product uses. |
| Cycle time, disclosure to filing decision | Whether the pipeline keeps pace with R&D and product development. Slow decisions kill inventor participation. |
The pipeline metrics
Disclosures per technologist per year measures whether invention is being captured or silently lost, and it is the metric most organizations find embarrassing first. Rates vary widely by industry, and typical organizations run well under one disclosure per technologist per year, so track your own trend rather than chasing a universal number. A low or falling rate almost always indicates a process problem rather than an invention shortage, because technologists are inventing regardless; the question is whether anything captures it.
Conversion rate and cycle time describe the machinery after capture. Conversion near 100 percent means triage applies no judgment; conversion near zero means technologists' effort is being wasted, and they will notice and stop submitting. Cycle time from disclosure to a filing decision is the inventor-experience metric: pipelines that take two quarters to say no kill their own supply.
The portfolio metrics
Share of filings mapped to shipping products is the alignment number, and the one worth showing the board: it states what fraction of the patent budget protects actual revenue. Citation and coverage measures against named competitors locate you in the landscape: who cites your filings, whose filings crowd your roadmap, and where white space remains. Maintenance spend by value tier closes the loop, asking whether escalating renewal fees concentrate on the patents that matter or leak into dead weight that mapping has already exposed.
Together the portfolio metrics answer the question CFOs eventually ask: what is the IP budget buying? A CTO with these three numbers has the answer before the question arrives.
What to do when a number is bad
Low disclosure rate: change the process rather than exhorting technologists. Facilitated capture removes the paperwork burden entirely, and our structured invention sessions consistently surface documented disclosures in volume, which often exceeds what an organization's voluntary process produces in a year. Broken conversion or cycle time: give the review committee explicit scoring criteria (commercial value, detectability, durability) and a service-level commitment to inventors.
Low product mapping or leaking maintenance spend: run a portfolio review, prune the dead weight, and redirect the freed renewal budget into the gaps. The KPIs are a dashboard rather than a fix, but they tell you which engagement actually pays.
Related questions
What is a healthy disclosure rate?
It varies too much by industry and R&D intensity for one number to be honest. Industry surveys suggest only about a third of technologists ever submit a disclosure, so most organizations have headroom. Set a baseline from your own last two years and manage the trend.
Is raw patent count a vanity metric?
On its own, mostly yes. Count says nothing about coverage, quality, or alignment. Count becomes meaningful only next to the mapping metric: a hundred patents with 80 percent mapped to products is a portfolio; a hundred with 20 percent mapped is a fee schedule.
Who should own this dashboard?
The pipeline metrics belong to R&D, engineering, or product-development leadership, because they measure how those teams capture and advance inventions. The portfolio metrics are usually shared with legal or an IP function. One quarterly review with both at the table beats two separate decks.
Can ipCG build the baseline for us?
Yes. Portfolio-to-product mapping, competitive citation analysis, and maintenance-tier review are standard fixed-scope engagements for us, and they produce the first version of every portfolio metric on this page. The pipeline metrics come from your own disclosure system once the definitions are set.
Stand up the dashboard with real numbers
Most of these KPIs can be baselined in a single fixed-scope engagement. A free discovery call is enough to scope which metrics your data already supports.
Talk with Our TeamRelated
ipCapital Group is a consultancy, not a law firm, and nothing on this page is legal advice. Dollar figures on this page are typical market ranges for professional IP services, drawn from published sources and industry experience across a variety of providers. They are not an ipCG quote or rate card; every ipCG engagement is individually scoped and priced. See how our pricing works.